Home  /  Resource Library  /  Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients

Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients

Study examined real world outcomes of chronic lymphocytic leukemia patients treated with venetoclax.